Please login to the form below

Not currently logged in
Email:
Password:

mouth cancer

This page shows the latest mouth cancer news and features for those working in and with pharma, biotech and healthcare.

NICE recommends Ibrance and Lynparza, rejects Keytruda and Xospata

NICE recommends Ibrance and Lynparza, rejects Keytruda and Xospata

on a number of key cancer drugs, with winners and losers across the board. ... NICE also found issue over a lack of separate clinical evidence for people whose cancer started outside the mouth, and incomplete information regarding Keytruda’s clinical

Latest news

  • NICE set to reject Merck’s Erbitux for head and neck cancer NICE set to reject Merck’s Erbitux for head and neck cancer

    Merck has since provided further evidence for Erbitux to assist this appraisal process, reducing the indication to patients with mouth cancer alone as well as proposing an additional, undisclosed discount. ... However, the committee said that the new

  • PR and Med Ed news in brief

    Mouth Cancer Awareness Week 2004 was the most successful mouth cancer campaign ever said the British Dental Health Foundation.

  • Ethnic Minority Cancer Awareness Week

    Sir Trevor McDonald is backing a campaign to raise levels of awareness about the affects of cancer on Black and Minority Ethnic communities. ... of mouth cancer and Bangladeshi and Chinese communities having a higher incidence of liver cancer.

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...